E
E. Ann Tallant
Researcher at Wake Forest University
Publications - 68
Citations - 6068
E. Ann Tallant is an academic researcher from Wake Forest University. The author has contributed to research in topics: Angiotensin II & Angiotensin II receptor type 1. The author has an hindex of 30, co-authored 64 publications receiving 5581 citations. Previous affiliations of E. Ann Tallant include Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Carlos M. Ferrario,Jewell A. Jessup,Mark C. Chappell,David B. Averill,K. Bridget Brosnihan,E. Ann Tallant,Debra I. Diz,Patricia E. Gallagher +7 more
TL;DR: Although the predominant effect of ACE inhibition may result from the combined effect of reduced Ang II formation and Ang-(1–7) metabolism, the antihypertensive action of AT1 antagonists may in part be due to increased Ang II metabolism by ACE2.
Journal ArticleDOI
Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors
Yuichiro Ishiyama,Patricia E. Gallagher,David B. Averill,E. Ann Tallant,K. Bridget Brosnihan,Carlos M. Ferrario +5 more
TL;DR: Evidence is provided for an effect of angiotensin II blockade on cardiac ACE 2 mRNA that may be due to direct blockade of AT1a receptors or a modulatory effect of increased angiotENSin-(1–7).
Journal ArticleDOI
Counterregulatory Actions of Angiotensin-(1-7)
TL;DR: The accumulating evidence suggests that Ang-(1-7) may oppose the actions of Ang II either directly or by stimulation of prostaglandins and nitric oxide, which may explain the effective antihypertensive action of converting enzyme inhibitors in a variety of non-renin-dependent models of experimental and genetic hypertension as well as most forms of human hypertension.
Journal ArticleDOI
Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
TL;DR: ANG-(1-7) is elevated after treatment with angiotensin-converting enzyme inhibitors or AT(1) receptor blockers and may contribute to their beneficial effects on cardiac dysfunction and ventricular remodeling after myocardial infarction.
Journal ArticleDOI
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
TL;DR: It is reported that Ang II and Ang-(1-7) differentially modulate rat aortic vascular smooth muscle cell growth and inhibition of proliferation appears to be mediated by a novel angiotensin receptor that is not inhibited by AT1 or AT2 receptor antagonists.